Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Investment Sources (NIS) is a private investment and financial services firm that specializes in providing capital and strategic advisory services to the healthcare and life sciences sectors. The company focuses on identifying high-growth opportunities within medical technology, healthcare services, and biotechnology, often facilitating funding for early-to-mid-stage companies. NIS leverages its industry expertise to assist healthcare organizations in navigating complex financial landscapes and securing the necessary resources for expansion and innovation. While not a drug developer itself, the firm plays a critical role in the healthcare ecosystem by bridging the gap between institutional capital and emerging medical ventures. Its services include private equity placements, debt financing, and strategic consulting tailored to the unique regulatory and operational demands of the health industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Investment Sources.